Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...
Research | January 9, 2025 |

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...
Knox Henderson | December 23, 2024 |

Not only balloons: Use-cases and key players in global helium market

Whether you’re seeking exposure to exploration upside or established profitability, the helium market offers compelling candidates for the commodity sleeve of your portfolio. Helium is an essential resource notable for its widespread use-cases and p...
Trevor Abes | September 5, 2024 |

AI as a winning model!

200% return with Super Micro Computer and BlockchainK2; caution with Intel and Aixtron! The high-tech wave has been quite pronounced so far in 2024. Even the correction in July had little impact on the strong trend, which is now continuing upward. However, inve...
André Will-Laudien | September 4, 2024 |

A world-class copper opportunity in Peru

The following is a transcription of the above video, and The Market Online has edited it for clarity . The Market Online recently caught up with Ivan Bebek, the co-founder and CEO of Coppernico Metals Inc , a mineral exploration company focused on creating value for...
Lyndsay Malchuk | July 30, 2024 |

Buzz on the Bullboards: From innovating traffic enforcement to cancer breakthroughs

The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector. The S&P 500 and NASDAQ have hit fresh highs, a clear sign of a hungry market bolstered by technology stocks. This momentum has put a spot...
Jonathon Brown | June 20, 2024 |

2024, a breakthrough year for silver

By Chen Lin, chenpicks.com For thousands of years, silver has been a globally recognized commodity. In China, silver was historically used as a standard form of currency, and the term “bank” in Chinese (银行) literally translates to “silver tradi...
Research | June 14, 2024 |

A Portuguese feast: EuroPacific Metals (EUP.V) digs in on a copper and gold smorgasbord

By Chris Parry Two things have changed about Canadian dinner parties over the last few years. The first is, people are less inclined to bring a sassy red and more inclined to bring edibles. And the second thing is, everyone’s going to Port...
Research | May 10, 2024 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Buzz on the Bullboards: Who’s filling the void in the tech selloff?

Last week was full of tough questions for investors navigating the waters of a sea of global economic uncertainty and confusion. Investors remain in a holding pattern as we witnessed some of the most popular companies among our communities (many in the tech sector) st...
Jonathon Brown | February 1, 2024 |
1 2 3 4 5 6 7 8 9 10 ...